| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Published online before print May 24, 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1-Derived Peptide, Interacts with Integrins and Increases Protease Activity of a Human Salivary Gland Adenoid Cystic Carcinoma Cell Line through the ERK 1/2 Signaling Pathway



From the Department of Cellular and Developmental Biology,* Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil; Center for Applied Toxinology,
Butantan Institute, São Paulo, Brazil; Universidade Metropolitana de Santos,
Santos, São Paulo, Brazil; Department of Biophysics,
Universidade Federal de São Paulo, São Paulo, Brazil; Department of Oral Pathology,¶ School of Dentistry, University of Pará, Belém, Pará, Brazil; and National Institute of Dental and Craniofacial Research,|| National Institutes of Health, Bethesda, Maryland
Adenoid cystic carcinoma is a frequently occurring malignant salivary gland neoplasm. We studied the induction of protease activity by the laminin-derived peptide, SIKVAV, in cells (CAC2) derived from this neoplasm. Laminin
1 and matrix metalloproteinases (MMPs) 2 and 9 were immunolocalized in adenoid cystic carcinoma cells in vivo and in vitro. CAC2 cells cultured on SIKVAV showed a dose-dependent increase of MMP9 as detected by zymography and colocalization of
3 and
6 integrins. Small interfering RNA (siRNA) knockdown of integrin expression in CAC2 cells resulted in decreased adhesion to the peptide. SIKVAV affinity chromatography and immunoblot analysis showed that
3,
6, and ß1 integrins were eluted from the SIKVAV column, which was confirmed by mass spectrometry and a solid-phase binding assay. Small interfering RNA experiments also showed that these integrins, through extracellular signal-regulated kinase (ERK) 1/2 signaling, regulate MMP secretion induced by SIKVAV in CAC2 cells. We propose that SIKVAV increases protease activity of a human salivary gland adenoid cystic carcinoma cell line through
3ß1 and
6ß1 integrins and the ERK 1/2 signaling pathway.
This article has been cited by other articles:
![]() |
E. Delamarre, S. Taboubi, S. Mathieu, C. Berenguer, V. Rigot, J.-C. Lissitzky, D. Figarella-Branger, L. Ouafik, and J. Luis Expression of Integrin {alpha}6{beta}1 Enhances Tumorigenesis in Glioma Cells Am. J. Pathol., August 1, 2009; 175(2): 844 - 855. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |